Biotech entity
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention CalMatters, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Rita F. Lin, all published on July 21, 2026.
Last mentioned: Jul 21, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: funding. Of the tracked stories, 1 of 1 also mention CalMatters, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Rita F. Lin, all published on July 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Rita F. Lin. Shared-story counts are live from our verified record — not editorial picks.
The Trump administration's use of keyword filters to cancel nearly $2 billion in UC research grants dealt a heavy blow to biomedical innovation, affecting studies from gene therapy to clinical trials. The legal admission exposes the unscientific basis for the terminations.
Rita F. Lin is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
